EasySep™小鼠TIL（CD45）正选试剂盒
产品号 #07909_C
细胞解离试剂
若您需要咨询产品或有任何技术问题，请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系
总览
使用IV型胶原酶（1mg/mL）生成适合传代的人胚胎干细胞（ES）或人诱导多能干细胞（iPS）细胞团块。该酶法细胞解离试剂也可用于将培养于饲养层细胞的人 ES 细胞或 iPS 细胞转移到无饲养层培养。IV 型胶原酶来源于溶组织梭菌，具有较低的胰蛋白酶活性，常用于需要维持受体完整性的应用。
包含
• 1 mg/mL Collagenase Type IV isolated from Clostridium histolyticum
• DMEM/F-12
亚型
酶法相关（或酶解类产品
别名
溶组织梭菌胶原酶；胶原酶4；4型胶原酶；胶原酶IV
种属
人，小鼠，非人灵长类，其它细胞系，大鼠
应用
细胞培养
产品说明书及文档
请在《产品说明书》中查找相关支持信息和使用说明，或浏览下方更多实验方案。
应用领域
本产品专为以下研究领域设计，适用于工作流程中的高亮阶段。探索这些工作流程，了解更多我们为各研究领域提供的其他配套产品。
相关材料与文献
技术资料 (2)
文献 (5)
A Concise Protocol for siRNA-Mediated Gene Suppression in Human Embryonic Stem Cells. Methods in molecular biology (Clifton, N.J.) 2016 FEB
Abstract
Human embryonic stem cells hold great promise for future biomedical applications such as disease modeling and regenerative medicine. However, these cells are notoriously difficult to culture and are refractory to common means of genetic manipulation, thereby limiting their range of applications. In this protocol, we present an easy and robust method of gene repression in human embryonic stem cells using lipofection of small interfering RNA (siRNA).
Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells. Nature communications 2014 SEP
Abstract
Human pluripotent stem cells (hPSCs) tend to acquire genomic aberrations in culture, the most common of which is trisomy of chromosome 12. Here we dissect the cellular and molecular implications of this trisomy in hPSCs. Global gene expression analyses reveal that trisomy 12 profoundly affects the gene expression profile of hPSCs, inducing a transcriptional programme similar to that of germ cell tumours. Comparison of proliferation, differentiation and apoptosis between diploid and aneuploid hPSCs shows that trisomy 12 significantly increases the proliferation rate of hPSCs, mainly as a consequence of increased replication. Furthermore, trisomy 12 increases the tumorigenicity of hPSCs in vivo, inducing transcriptionally distinct teratomas from which pluripotent cells can be recovered. Last, a chemical screen of 89 anticancer drugs discovers that trisomy 12 raises the sensitivity of hPSCs to several replication inhibitors. Together, these findings demonstrate the extensive effect of trisomy 12 and highlight its perils for successful hPSC applications.
Trisomy 21 mid-trimester amniotic fluid induced pluripotent stem cells maintain genetic signatures during reprogramming: implications for disease modeling and cryobanking. Cellular reprogramming 2014 OCT
Abstract
Trisomy 21 is the most common chromosomal abnormality and is associated primarily with cardiovascular, hematological, and neurological complications. A robust patient-derived cellular model is necessary to investigate the pathophysiology of the syndrome because current animal models are limited and access to tissues from affected individuals is ethically challenging. We aimed to derive induced pluripotent stem cells (iPSCs) from trisomy 21 human mid-trimester amniotic fluid stem cells (AFSCs) and describe their hematopoietic and neurological characteristics. Human AFSCs collected from women undergoing prenatal diagnosis were selected for c-KIT(+) and transduced with a Cre-lox-inducible polycistronic lentiviral vector encoding SOX2, OCT4, KLF-4, and c-MYC (50,000 cells at a multiplicity of infection (MOI) 1-5 for 72 h). The embryonic stem cell (ESC)-like properties of the AFSC-derived iPSCs were established in vitro by embryoid body formation and in vivo by teratoma formation in RAG2(-/-), $\$-chain(-/-), C2(-/-) immunodeficient mice. Reprogrammed cells retained their cytogenetic signatures and differentiated into specialized hematopoietic and neural precursors detected by morphological assessment, immunostaining, and RT-PCR. Additionally, the iPSCs expressed all pluripotency markers upon multiple rounds of freeze-thawing. These findings are important in establishing a patient-specific cellular platform of trisomy 21 to study the pathophysiology of the aneuploidy and for future drug discovery.
更多信息
| 种属 | Human, Mouse, Non-Human Primate, Other, Rat |
|---|---|
| Contains | • 1 mg/mL Collagenase Type IV isolated from Clostridium histolyticum • DMEM/F-12 |
| Alternative Names | Clostridium histolyticum collagenase; Collagenase 4; Collagenase Type 4; Collagenase IV |
相关产品
-
I型胶原酶（0.25%）细胞解离试剂
-
胶原酶/透明质酸酶配置于DMEM中的10 X 胶原酶/透明质酸酶
-
Dispase（5 U/mL）含 5 U/mL Dispase 的 Hanks’ 平衡盐溶液（HBSS）
-
温和胶原酶/透明质酸酶配置于DMEM中的10X温和胶原酶/透明质酸酶
